Wednesday 24 July 2019

Reuters Health Report: Samsung Bioepis Humira biosimilar wins FDA approval

Reuters.com Newsletter

Samsung Bioepis Humira biosimilar wins FDA approval

(This story corrects to show that Hadlima belongs to Samsung Bioepis not Merck & Co Inc, which is commercializing the drug in the United States)

African swine fever hits another pig farm in Bulgaria

Bulgaria has detected another outbreak of African swine fever at a pig breeding farm near the north eastern city of Ruse, after the deadly virus was discovered earlier this month, the food safety agency said on Wednesday.

U.S. coal miners discouraged by black lung meeting with McConnell

A group of coal miners afflicted with black lung disease met with Senate Majority Leader Mitch McConnell on Tuesday as part of an effort to convince lawmakers to restore a higher excise tax on coal companies to help fund their medical care, but several said the meeting left them discouraged.

Letterbox campaign helps Afghans cope with silent war of mental health

Hundreds of Afghans, weary of war and unsure of the future, have joined a letter-writing campaign to share their feelings with the powerful few who will decide on peace with the Taliban and, with it, the fate of their country.

Heart attacks, strokes increase when patients can't afford newer cholesterol drugs

(Reuters Health) - Patients at high risk for heart disease who cannot afford newer cholesterol-lowering medications are more likely to have heart attacks, strokes and other cardiovascular events within just one year compared to counterparts who were able to get the drugs, a new study suggests.

Genetics play bigger role in autism risk than environmental factors

(Reuters Health) - Most of the variation in risk for autism may be explained by genetics rather than differences in environmental factors like lifestyle or community characteristics or certain pregnancy outcomes, a study in five countries suggests.

Medicare-for-all might not cause surge in hospital use

(Reuters Health) - Medicare-for-all and other versions of universal coverage being proposed for the U.S. by several presidential hopefuls wouldn't necessarily lead more people to seek hospital care, a new analysis suggests.

Senators announce bipartisan proposal to lower drug prices

The top Republican and Democrat on the U.S. Senate Finance Committee announced a proposal to lower prescription drug prices on Tuesday that could save $100 billion in costs to government healthcare programs, and said the committee would vote on the legislation on Thursday.

Short-term opioids for pain still come with side effects

(Reuters Health) - Patients who only briefly take opioid painkillers are still likely to face side effects, a new study suggests.

Multiple sclerosis drug helps Biogen beat Wall St. profit expectations

Biogen Inc reported better-than-expected second quarter profit and raised its 2019 earnings forecast on Tuesday, driven by higher sales of its top-selling multiple sclerosis drug Tecfidera and lower taxes.

China's agri ministry emphasizes need to ensure stable hog market

China's agriculture ministry said on Tuesday that it would work to ensure the country's pork supplies and to keep the hog market stable despite the spread of the African swine fever virus.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS